$6.14
-$0.07
(-1.13%)
Quote as of 2:11 PM EST on 02/10/12
Targacept , Inc.
NASDAQ:TRGT
|
$6.14
|
|
| Today's Open | $6.18 |
|---|---|
| Previous Close | $6.21 |
| Daily Range | $6.04 - $6.28 |
| 52-Week Range | $4.91 - $30.47 |
| Market Cap | $204.97M |
| P/E Ratio | -207.00 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 79,466 |
| Average Daily Volume | 363,206 |
| Current FY EPS | -$0.26 |
TRGT Information
| Description |
|---|
| A biopharmaceutical company engaged in the design, discovery and development of NNR Therapeutics, a new class of drugs for the treatment of multiple diseases and disorders of the central nervous system. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
Targacept Sees More AstraZeneca Backing On Alzheimer's Drug
The Worst Health Care Stocks of 2011
5 of Last Week's Biggest Losers
Last Week's Biggest Stock Laggards
The Market Just Spanked My Stock!
US Stock Futures: HOT STOCKS TO WATCH
UPDATE: AstraZeneca/Targacept Antidepressant Misses Study Goal
S&P 500's Big Spenders Beat Top Savers in 2011
This $581 Doughnut Hole Costs Drugmakers
